CLX Quote, Financials, Valuation and Earnings

Colgate-Palmolive has a net margin of 11.15% compared to Clorox's net margin of 14.05%. Clorox's return on equity of 270.67% beat Colgate-Palmolive's return on equity of 450.97%.

Clorox has a consensus price target of $142.95, signalling upside risk potential of 12.65%. On the other hand Colgate-Palmolive has an analysts' consensus of $98.11 which suggests that it could grow by 11.92%. Given that Clorox has higher upside potential than Colgate-Palmolive, analysts believe Clorox is more attractive than Colgate-Palmolive.

Clorox has a beta of 0.509, which suggesting that the stock is 49.096% less volatile than S&P 500. In comparison Colgate-Palmolive has a beta of 0.372, suggesting its less volatile than the S&P 500 by 62.782%.

Clorox has a quarterly dividend of $1.22 per share corresponding to a yield of 3.85%. Colgate-Palmolive offers a yield of 2.3% to investors and pays a quarterly dividend of $0.52 per share. Clorox pays 212.5% of its earnings as a dividend. Colgate-Palmolive pays out 61.93% of its earnings as a dividend. Colgate-Palmolive's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Clorox's is not.

Clorox quarterly revenues are $1.7B, which are smaller than Colgate-Palmolive quarterly revenues of $4.9B. Clorox's net income of $186M is lower than Colgate-Palmolive's net income of $690M. Notably, Clorox's price-to-earnings ratio is 22.78x while Colgate-Palmolive's PE ratio is 24.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clorox is 2.25x versus 3.61x for Colgate-Palmolive. Usually stocks with elevated PS ratios are considered overvalued.

Kenvue has a net margin of 11.15% compared to Clorox's net margin of 8.61%. Clorox's return on equity of 270.67% beat Kenvue's return on equity of 10.32%.

Clorox has a consensus price target of $142.95, signalling upside risk potential of 12.65%. On the other hand Kenvue has an analysts' consensus of $24.16 which suggests that it could grow by 10.57%. Given that Clorox has higher upside potential than Kenvue, analysts believe Clorox is more attractive than Kenvue.

Clorox has a beta of 0.509, which suggesting that the stock is 49.096% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Clorox has a quarterly dividend of $1.22 per share corresponding to a yield of 3.85%. Kenvue offers a yield of 3.75% to investors and pays a quarterly dividend of $0.21 per share. Clorox pays 212.5% of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Clorox quarterly revenues are $1.7B, which are smaller than Kenvue quarterly revenues of $3.7B. Clorox's net income of $186M is lower than Kenvue's net income of $322M. Notably, Clorox's price-to-earnings ratio is 22.78x while Kenvue's PE ratio is 39.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clorox is 2.25x versus 2.75x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.

Procter & Gamble has a net margin of 11.15% compared to Clorox's net margin of 19.06%. Clorox's return on equity of 270.67% beat Procter & Gamble's return on equity of 30.14%.

Clorox has a consensus price target of $142.95, signalling upside risk potential of 12.65%. On the other hand Procter & Gamble has an analysts' consensus of $171.79 which suggests that it could grow by 11.75%. Given that Clorox has higher upside potential than Procter & Gamble, analysts believe Clorox is more attractive than Procter & Gamble.

Clorox has a beta of 0.509, which suggesting that the stock is 49.096% less volatile than S&P 500. In comparison Procter & Gamble has a beta of 0.405, suggesting its less volatile than the S&P 500 by 59.527%.

Clorox has a quarterly dividend of $1.22 per share corresponding to a yield of 3.85%. Procter & Gamble offers a yield of 2.65% to investors and pays a quarterly dividend of $1.06 per share. Clorox pays 212.5% of its earnings as a dividend. Procter & Gamble pays out 62.59% of its earnings as a dividend. Procter & Gamble's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Clorox's is not.

Clorox quarterly revenues are $1.7B, which are smaller than Procter & Gamble quarterly revenues of $19.8B. Clorox's net income of $186M is lower than Procter & Gamble's net income of $3.8B. Notably, Clorox's price-to-earnings ratio is 22.78x while Procter & Gamble's PE ratio is 24.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clorox is 2.25x versus 4.51x for Procter & Gamble. Usually stocks with elevated PS ratios are considered overvalued.